WHO ICTRP trial
Study on the Efficacy of Shexiang Baoxin Pill in the Treatment of Coronary…
ChiCTR2600116679 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2600116679 |
|---|---|
| Public title | Study on the Efficacy of Shexiang Baoxin Pill in the Treatment of Coronary Microvascular Disease Based on TCM Syndrome Types |
| Scientific title | Study on the Efficacy of Shexiang Baoxin Pill in the Treatment of Coronary Microvascular Disease Based on TCM Syndrome Types |
| Primary sponsor | Dongzhimen Hospital, Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Coronary Microvascular Disease |
| Interventions | Shexiang Baoxin Pill group:Rosuvastatin calcium tablets, 10 mg once daily+Shexiang Baoxin Pills (Shanghai Hutchison Pharmaceuticals), 2 pills three times daily.;Nicorandil group:Rosuvastatin calcium tablets, 10 mg once daily+nicorandil… |
| Registration date | Jan 13, 2026 |
| Target size | Shexiang Baoxin Pill group:25;Nicorandil group:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: